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Micropuncture localization of kallikrein secretion in the rat
nephron
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Micropuncture localization of kallikrein secretion in the rat nephron.
We have used free—flow micropuncture to study the tubular locus at
which kallikrein enters the urine. Kallikrein was measured by a newly
developed, very sensitive assay for kininogenase activity; active kal-
likrein was measured directly by this assay and total kallikrein after
activation of inactive kallikrein. Kallikrein was readily detected in all of
17, late distal tubular fluid—samples. In contrast, kallikrein was too low
to detect in 15 of 17 proximal or in 11 of 14 early distal tubular fluid
samples. Calculations indicate that less than 10% of urinary kallikrein
could have derived from filtration or from proximal secretion of
kallikrein. We conclude that urinary kallikrein enters the urine via
secretion in the distal tubule. Filtration or proximal secretion of
kallikrein does not contribute significantly to urinary kallikrein excre-
tion.
Microdissection and histochemical observations indicate that
renal kallikrein is predominantly localized to the distal portions
of the nephron, with especially high concentration in the
connecting tubule segments [1—7]. Little or no enzyme is
present in the proximal tubule, loop of Henle, medullary
collecting ducts or glomeruli [3—6]. These data suggest that
kallikrein is secreted into the urine principally by the connect-
ing tubule. In addition, a distal locus of secretion has been
demonstrated by a stop—flow study in the dog, which indicated
that kallikrein is added to distal tubular fluid [8]. However,
these data do not preclude the possibility that urinary kallikrein
represents a combination of renal filtration of circulating tissue
kallikrein and kallikrein secreted by the renal tubules. In fact
studies by Fink and Schleuning [9] have suggested that renal
clearance of circulating kallikrein may account for as much as
66% of urinary kallikrein.
We have developed a specific kallikrein assay which is
sensitive enough to detect kallikrein in tubular fluid samples
obtained by micropuncture. Using free—flow micropuncture
methods we have demonstrated directly that kallikrein is se-
creted into distal tubular urine. We have also found that little or
no urinary kallikrein is derived from other sources, including
filtration of circulating glandular kallikrein.
Methods
Micropuncture experiments
Experiments were performed on male Sprague—Dawley rats
which were fed Purina rat chow (1% NaCl) and tap water ad
libitum until the morning of the experiment. They were anes-
thetized with mactin (100 mg/kg) and prepared for snicropunc-
ture as previously described [10]. The left ureter and bladder
were cannulated for collection of urine from the left and right
kidney, respectively. Tubular fluid collections were made at
least 30 minutes after surgery and only if proximal transit time
was less than 15 seconds and blood pressure was greater than 90
mm Hg.
Early proximal, late proximal, early distal and late distal
segments were identified by i.v. injection of 0.05 ml FD&C Blue
dye. "Early" and "late" proximal tubules were identified as
the first and last superficial loop of a given nephron. "Early"
and "late" distal refer respectively to the first and the last distal
segment in which dye appeared within a microscopic field. Each
collection was made for 5 to 30 minutes, using an oil block to
permit complete collection of tubular fluid. Individual distal
tubular fluid samples were assayed for kallikrein. For proximal
samples, four to eight collections were pooled in order to
determine whether kallikrein was present in proximal tubular
fluid at low levels which otherwise might be below the limit of
detectability of the assay. Samples for active and total kallikrein
measurements were collected from separate groups of rats (N =
17 and N = 10, respectively).
Microkininogenase assay
A microanalytical modification of our standard assay for
urinary active kallikrein [11] was developed (Oza et al, in
preparation). Briefly, in this assay tubular fluid was incubated
with substrate and the kinins generated were analyzed by a
sensitive radioimmunoassay (RIA). Tubular fluid, in nanoliter
volumes, was delivered directly from the collection pipette into
25 pi of buffer and stored at —70°C until analyzed. The
substrate was pure bovine, low molecular—weight kininogen
(Seikagaku Kogyo Company Limited, Japan). The tubular fluid
in 25 .d buffer and 10 g kininogen were incubated for five
hours at 37°C. The reactions were terminated by heating at
100°C for five minutes. The kinins were extracted with ethanol.
The ethanol was evaporated and the kinins redissolved in
buffer. Duplicate aliquots were analyzed by our kinin RIA,
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modified to enhance sensitivity. Modifications were: 1.) a highly
sensitive bradykinin antiserum; and 2.) separation of bound and
free antigen was accomplished with the use of particle—bound,
goat—anti-rabbit immunoglobulins. Using these modifications,
the sensitivity of the kinin RIA was increased about 25-fold and
the standard curve was now obtainable between 1 and 100
pg/tube. Several substrate blanks and internal standards (dilu-
tions of a well characterized rat urine pool) were always run
with each assay. The microkininogenase assay had intra-assay
variability (C.V.) of 15.8% (N = 7 replicate analyses) and
inter-assay C.V. of 18.6% (N = 10 replicate assays). Recovery
of standard bradykinin was 108% 4% mean SEM (N = 9). In
preliminary experiments, tubular fluid samples were assayed
without incubation with substrate; preformed kinin was not
detectable.
Activation of inactive kallikrein in tubular fluid
High purity Triton X-100 (Pierce Chemical Company,
Rockford, Illinois, USA) was used to activate inactive kal-
likrein in the tubular fluid samples, using the method reported
by Erdos and Yamada [121 for activation of membrane bound
kallikrein. Tubular fluid samples in buffer and 5 pA of diluted
Triton X-l00 were mixed, so that the effective strength of the
Triton was 0.1% vol/vol. The activated tubular fluids were then
incubated with kininogen and kinin assayed as described in the
previous section. Substrate blanks containing Triton were al-
ways used in these assays.
Activation of kallikrein by tritonization was documented in
two ways. First, we compared the activation of kallikrein in a
well—characterized rat urine pool by this method and by trypsin.
Before activation, kininogenase activity was 71 3 pg kinin/5
hr incubation/nl urine. It increased to 104 6 after tritonization
and to 115 17 after trypsinization. In addition, we determined
the ratio of active and total kallikrein in ureteral urine of 10 rats
used for the present micropuncture studies, using the tritoniza-
tion method. Active kallikrein was 67% 9% of total kallikrein
excretion. We have previously reported [13] that active kal-
likrein is 66% to 70% of total kallikrein using trypsinization and
determination of immunoreactive kallikrein. These data provide
strong evidence that activation of kallikrein with Triton in the
microassay is comparable to activation of urinary kallikrein by
trypsinization, the standard method. Therefore, triton activated
samples are reported as total kallikrein.
All kallikrein measurements are reported as units of
kininogenase activity. One unit is defined as one pg of kinin
generated during a five hour incubation with substrate. All
urinary kallikrein measurements were made on 1 to 2 nI of urine
using the same microkininogenase assay used for tubular fluid
samples.
Results
Both active and total kallikrein were consistently found in
late distal tubular—fluid, whereas little or no kallikrein was
found at early proximal, late proximal or early distal sites. The
rates at which kallikrein was collected at each nephron segment
are shown in Figures 1 and 2. Kallikrein measurements are
represented as detectable (solid circle) if the kinin generating
activity of the sample was greater than or equal to the activity
of our lowest standard. Kallikrein was detectable in only two
early proximal pools out of 17 proximal pools tested. Since
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Fig. 1. Rate of active kallikrein collection from nephron segments of
the rat. Symbols are: (S) kallikrein measurements greater than or equal
to the lowest standard; (0) kallikrein measurements less than the lowest
standard.
these pools represented 40 minutes of tubular fluid collection,
the calculated rate at which kallikrein appeared at the early
proximal site was minimal compared to the corresponding rate
at the late distal site. The remaining proximal pools which had
no detectable kallikrein activity also represented long collection
times, varying between 20 and 75 minutes. Similarly, the
majority of early distal samples had no detectable kallikrein
activity. Although kallikrein was detectable in three of fourteen
early distal samples, activity was low in two of the three
samples. Both active and total kallikrein was readily detected in
all 18 late distal samples tested.
In Figure 3, the rate at which kallikrein was collected at the
late distal segment is compared to urinary kallikrein excretion
from the micropuncture kidney. Urinary excretion has been
divided by 30,000, as an estimate of the total excretion to be
"expected" in each nephron. This estimate is based on three
asumptions: the rat kidney contains 30,000 nephrons [14], the
secretory rate in each nephron is equal, and all urinary kal-
likrein is secreted before the late distal micropuncture site.
Active kallikrein detected at the late distal puncture—site was
48% 8% of the expected excretion rate per nephron. Total
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kallikrein was 58% 17% of the expected excretion per
nephron.
Comparisons between active and total kallikrein in late distal
fluid are not meaningful in these studies (Fig. 1 vs. Fig. 2), since
these measurements were made in different rats. By chance,
total late distal kallikrein—measurements were made in rats
which had lower urinary kallikrein excretion—rates than rats in
which active kallikrein was measured in late distal fluid. Active
kallikrein excretion was 247, 418 and 530 x i03 units/mm in
three rats in which total kallikrein was measured in late distal
fluid and 387, 507, 720, 772, 781, 888, 1320 and 2021 X i0
units/mm in the eight rats in which active late distal—kallikrein
was measured.
Tubular fluid collection rates were 25 1 nI/mm (N = 8) for
early proximal, 20 1 ni/mm (N 6) for late proximal, 7.4
0.5 (N = 16) for early distal and 4.8 0.5 nI/mm (N = 17) for
late distal samples. SNGFR measured in a separate group of
rats (N = 8), was 32 1 nllmin determined by proximal tubule
collections and 29 2 ni/mm determined by distal tubule
collections. Active kallikrein excretion from the left micropunc-
ture kidney (780 90 x iounits/mm, including all rats studied,
N = 22) was not significantly different from that of the contra-
lateral kidney (840 120 x i03 units/mm, N = 22), indicating
that manipulation of the kidney for micropuncture does not
significantly affect kallikrein excretion.
Discussion
Evidence for the renal origin of urinary kallikrein includes
demonstration of renal synthesis [15—17], localization of renal
kallikrein in distal tubular segments [1—6] and entry of kallikrein
into the urine at the level of the distal nephron using stop—flow
techniques [8]. Our data demonstrate directly and quantita-
tively that kallikrein enters the urine in large amounts between
the first and last distal segments detectable on the surface of the
rat kidney. This location fits with many studies on the localiza-
tion of kallikrein in distal tubular segments of the rat nephron.
Using microdissection techniques, the highest content of renal
kallikrein has been found in the connecting tubule with signifi-
cant amounts also present in the distal convoluted tubule and
the cortical collecting duct [1—3]. Figueroa et al [71, using
immunoelectron microscopic techniques in the rat, found kal-
likrein was specific to connecting tubule cells which have a
similar distribution along the distal nephron.
Since late distal tubule puncture—sites identified by dye
injection correspond to initial collecting tubule [18, 19], most
renal kallikrein should enter the urine prior to the late distal
segment. Our studies confirm that a large amount of kallikrein
does enter prior to the late distal site. However, when we
compared the amount of kallikrein present in late distal tubular
fluid to that expected to be secreted per nephron, assuming
equal release by 30,000 nephrons [14], we found that active and
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Fig. 2. Rate of total kallikrein collection from various nephron seg-
ments. Symbols are as in Figure 1.
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Fig. 3. Comparison of kallikrein in late distal tubular—fluid and the
calculated "expected" excretion rates per nephron. Symbols are: (•)
active kallikrein; (D) total kallikrein.
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total kallikrein detected in the late distal tubule were only about
one—half of the expected release per nephron. There are a
number of possible reasons for this difference. First, the late
distal puncture site may not regularly be beyond the entire
portion of the distal nephron which secretes kallikrein. Proud,
Knepper and Pisano [3] estimated that 33% of distal nephron
kallikrein is located in the initial collecting tubule and cortical
collecting duct. Our data indicate that as much as one—half of
the kallikrein in the urine may enter in cortical or medullary
segments beyond the last loop available for puncture on the
surface of the kidney. Secondly, superficial nephrons may
secrete less kallikrein than other nephrons. It is now well
recognized that superficial nephrons differ in a number of
functional and anatomical characteristics from midcortical and
juxtamedullary nephrons. For example, in the midcortical and
juxtamedullary zones several distal nephrons join, forming
arcades. Although arcades are thought to be lined with initial
collecting tubule epithelia in the rat [3], kallikrein secretion by
the arcades may account for part of the difference between late
distal and urinary kallikrein. Another possible reason for the
discrepancy between late distal kallikrein and urinary kallikrein
is that we underestimated the number of nephrons in the rat
kidney. Estimates vary between 30,000 and 38,000, and evi-
dence has been presented that 38,000 is a better estimate for the
mature rat [20, 21]. By using a value of 30,000 for our calcula-
tions, we may have overestimated the expected release per
nephron. Finally, it is possible that puncture of the tubular
epithelium somehow reduces the rate of kallikrein release,
although there is no specific reason to postulate such an effect.
Kallikrein was detected in 3 of 16 early distal samples. The
"early" distal tubule as defined by dye transit times is thought
to correspond to epithelia of the distal convoluted tubule [18,
19]. The presence of kallikrein in a few early distal samples may
indicate that some kallikrein is secreted by this or prior seg-
ments. It seems more likely that the few positive samples are
due to inaccuracies in identifying tubular segments by dye
transit times.
Fink and Schleuning [9] infused pig kallikrein into dogs and
detected substantial pig kallikrein in the urine. From these data
and with the assumption that infused pig kallikrein is handled
like endogenous circulating tissue—kallikrein, they concluded
that filtered kallikrein may constitute up to 66% of urinary
kallikrein in the dog. However, endogenous tissue kallikrein in
plasma (believed to be derived from various organs including
pancreas, salivary glands, etc.) is largely bound to plasma
inhibitors [22]. Inhibitor bound kallikrein is a large complex
which probably is not excreted or metabolized by the kidney
[23]. One objective of the present study was to determine what
fraction of urinary kallikrein, if any, is derived from filtration of
circulating tissue kallikrein. Kallikrein was not detectable in 15
of 17 pooled proximal fluid samples (4 to 8 nephrons per
sample). To evaluate the possibility that non-detectable
amounts of kallikrein could have contributed significantly to
urinary kallikrein, we calculated the maximal amount of kal-
likrein which could have been present in each of the proximal
pools and compared it to the rate of urinary kallikrein excretion
in the corresponding rat. The lowest standard varied between
20 and 40 units of kallikrein among assays. Total collection time
for each proximal pool varied between 20 and 75 minutes. By
calculation, the maximum amount of kallikrein in the early or
late proximal tubular fluid samples which could have escaped
detection ranged from 0.4 to 1.0 units of kallikrein per minute of
collection. This represents less than 2% to 7% of the kallikrein
present in urine samples obtained from the same rat. Even the
two early proximal samples which demonstrated low but mea-
surable activity would represent only 4% and 8%, respectively,
of the expected excretion per nephron. Thus our measurements
indicate that filtration of circulating kallikrein contributes less
than a few percent of urinary kallikrein excretion.
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